• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 32 of 100
U.K. Prime Minister Boris Johnson holding a vial of AstraZeneca's Covid-19 vaccine.
Health
U.K. approves AstraZeneca COVID-19 vaccine
By Jeremy KahnDecember 30, 2020
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
Health
Seniors face steep drug costs as Congress stalls on capping Medicare out-of-pockets
By Harris Meyer and Kaiser Health NewsDecember 28, 2020
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
Health
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
By Viren Vaghela, Thomas Penny and BloombergDecember 28, 2020
COVID vaccine CDC allergies
Health
What to know about the CDC’s new COVID vaccine guidance for people with health conditions
By Sy MukherjeeDecember 27, 2020
Doctors and patients face a painkiller crisis, even as they fight COVID
Commentary
Doctors and patients face a painkiller crisis, even as they fight COVID
By Joseph StaufferDecember 16, 2020
Big Pharma’s new CEOs must step up to erase inequities in drug access
Commentary
Big Pharma’s new CEOs must step up to erase inequities in drug access
By Jayasree K. IyerDecember 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
Finance
Why shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
Coronavirus
Health
The science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
Protein folding image for Eye on A.I.
Newsletters
Lessons from DeepMind’s breakthrough in protein-folding A.I.
By Jeremy KahnDecember 1, 2020
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
Tech
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
By Jeremy KahnNovember 30, 2020
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
Health
DeepMind’s new protein-folding A.I. is already helping in the fight against COVID-19
By Jeremy KahnNovember 30, 2020
A picture of a protein shape.
Tech
In a major scientific breakthrough, A.I. predicts the exact shape of proteins
By Jeremy KahnNovember 30, 2020
COVID vaccine FDA timeline
Health
It may be a matter of weeks, not months, before Americans can start getting COVID vaccines
By Sy MukherjeeNovember 28, 2020
Syringe shown against the AstraZeneca logo
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
Health
For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers
By Angelica LaVito, John Lauerman and BloombergNovember 25, 2020
1...
  • 30
  • 31
  • 32
  • 33
  • 34
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Mark Zuckerberg feeds his cows macadamia nuts and beer to create the 'highest-quality beef in the world' on his $300 million estate in Hawaiiplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Success
Today, Emily Blunt is worth $80 million thanks to her Hollywood career—but she actually wanted to be a UN Spanish translator on $80Kplaceholder alt text
By Orianna Rosa RoyleJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.